Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-11

Clinical Trial Update: Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB) [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early Phase 1 study evaluating sacral neuromodulation for refractory overactive bladder, sponsored by Beijing Pins Medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Pins Medical Co., Ltd | Conditions: Refractory Overactive Bladder | EARLY_Phase 1 | Status: UNKNOWN